These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7177261)

  • 1. The management of acute non-lymphocytic leukaemia in adults. Evaluation of the results in a non-selected group of 114 patients.
    Dekker AW; Sixma JJ; Punt K
    Neth J Med; 1982; 25(9):297-302. PubMed ID: 7177261
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology Group.
    Bodey GP; Coltman CA; Hewlett JS; Freireich EJ
    Arch Intern Med; 1976 Dec; 136(12):1383-8. PubMed ID: 1069570
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of childhood acute non-lymphocytic leukemia with the AVC regimen (adriamycin, vincristine and cytosine arabinoside)].
    Tonouchi T; Toyoda Y; Mimaya J
    Rinsho Ketsueki; 1987 Sep; 28(9):1528-32. PubMed ID: 3437513
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential vincristine, arabinosylcytosine and adriamycin in acute leukemia: cytologic and cytokinetic studies.
    Riccardi A; Mazzini G; Montecucco C; Cresci R; Traversi E; Berzuini C; Ascari E
    Cytometry; 1982 Sep; 3(2):104-9. PubMed ID: 7140479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia.
    Wiernik PH
    Cancer Treat Rep; 1981; 65 Suppl 4():67-71. PubMed ID: 7049382
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of acute leukemias in adults. II. Preliminary analysis of the treatment results according to AR and RAMP programs].
    Janowska-Wieczorek A; Pawelski S; Maj S; Apel D; Gepner-Woźniewska M
    Acta Haematol Pol; 1981; 12(3-4):137-45. PubMed ID: 7342654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with acute non-lymphocytic leukemia who fail first cycle of induction therapy.
    Hasbrouck DJ; Peterson BA; Hurd DD; Bloomfield CD
    Leuk Res; 1981; 5(4-5):357-61. PubMed ID: 7289645
    [No Abstract]   [Full Text] [Related]  

  • 8. Probable cures of adult acute leukemia using short term intensive investigational chemotherapy.
    Vaughan WP; Karp JE; Burke PJ
    Nebr Med J; 1984 Aug; 69(8):264-8. PubMed ID: 6483053
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACNP therapy for DCMP-resistant acute leukemia (author's transl)].
    Naoe T; Hiraiwa A; Akao Y; Tahara T; Yoshikawa H; Yoshikawa S; Naito K; Yamaguchi H
    Rinsho Ketsueki; 1981 Oct; 22(10):1538-44. PubMed ID: 6460886
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes of therapy results in acute leukemia under different treatment schedules with special reference to gnotobiotic measures].
    Link H; Frauer HM; Wilms K; Waller HD
    Klin Wochenschr; 1983 Apr; 61(7):329-38. PubMed ID: 6575217
    [No Abstract]   [Full Text] [Related]  

  • 11. [First clinical experiences with a modified COAP schedule in acute leukoses of adults].
    Gerecke D; Kaulen HD; Hirschmann WD; Voigtmann R; Gross R
    Verh Dtsch Ges Inn Med; 1975; 81():1116-9. PubMed ID: 1229412
    [No Abstract]   [Full Text] [Related]  

  • 12. Biphenotypic acute leukaemia: a case series.
    Aribi A; Bueso-Ramos C; Estey E; Estrov Z; O'Brien S; Giles F; Faderl S; Thomas D; Kebriaei P; Garcia-Manero G; Pierce S; Cortes J; Kantarjian H; Ravandi F
    Br J Haematol; 2007 Jul; 138(2):213-6. PubMed ID: 17593028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
    Rigacci L; Carrai V; Nassi L; Alterini R; Longo G; Bernardi F; Bosi A
    Cancer; 2005 Mar; 103(5):970-7. PubMed ID: 15666323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High remission induction (traditional sino-western HOAP) regimen for acute nonlymphocytic leukemia.
    Chin Med J (Engl); 1980 Aug; 93(8):565-8. PubMed ID: 6772409
    [No Abstract]   [Full Text] [Related]  

  • 15. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission-induction, consolidation and maintenance therapy by AVA protocol in acute nonlymphoblastic leukemia.
    Torlontano G; Geraci L; Lombardo M; Di Marzio A; Iacone A; Fioritoni G; Bonanni G; Di Bartolomeo P; Ballone E; D'Antonio D; Di Girolamo G; D'Arcangelo L; Pandoli G; Natale D; Spadano A
    Haematologica; 1982 Apr; 67(2):230-45. PubMed ID: 6807770
    [No Abstract]   [Full Text] [Related]  

  • 17. Doxorubicin and ifosfamide combination chemotherapy in previously treated acute leukemia in adults: a Southwest Oncology Group pilot study.
    Ryan DH; Bickers JN; Vial RH; Hussein K; Bottomley R; Hewlett JS; Wilson HE; Stuckey WJ
    Cancer Treat Rep; 1980; 64(8-9):869-72. PubMed ID: 7448824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of acute myeloid leukemia with an intense chemotherapeutic regimen and variable reduction of the dosage for elderly patients].
    Whittaker JA
    Clin Ter; 1982 Sep; 102(5):435-41. PubMed ID: 6960975
    [No Abstract]   [Full Text] [Related]  

  • 19. [High-dose cytosine arabinoside therapy in refractory acute leukemia].
    Yorimitsu S; Takahashi I; Kitazima K; Kimura I; Hara M; Tokuda M
    Rinsho Ketsueki; 1984 Dec; 25(12):1941-6. PubMed ID: 6533329
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of childhood acute nonlymphocytic leukemia with individually scheduled high doses of cytarabine: preliminary results of study ANLL-82 of the Dutch Childhood Leukemia Study Group (DCLSG).
    Hählen K; van der Does-van den Berg A; Colly LP; Smets LA; Taminiau JA; Vossen JM
    Haematol Blood Transfus; 1987; 30():389-92. PubMed ID: 3305208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.